Navigation Links
Kemwell Announces Successful Pre-NDA US FDA Inspection
Date:1/31/2013

BANGALORE, January 31, 2013 /PRNewswire/ --

Kemwell Biopharma Pvt. Ltd., a global pharmaceutical contract development and manufacturing company, announced today that its Oral Solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection. The cGMP Audit for a Pre-Approval Inspection (PAI) was triggered by an NDA filing by one of the top ten global pharmaceutical companies. Kemwell has manufactured numerous products for the European markets for top pharmaceutical companies. This project is part of a growing effort to serve the US market.

"The approval from the US FDA confirms Kemwell's cGMP manufacturing capability and regulatory compliance, and our commitment to provide our customers the highest standards of quality. The facility has been approved by many global regulatory authorities including EMA, MHRA, Health Canada and TGA. We will continue to strive to provide excellent quality pharmaceutical products and deliver on the highest customer service expectations," says Anurag Bagaria , Chairman and Managing Director, Kemwell Biopharma.

Applying Quality by Design (QbD) principles, Kemwell's R&D and manufacturing teams in conjunction with the customer, optimized tablet formulation, conducted process scale-up studies to define design space for manufacturing of tablet formulation, and manufactured the validation and submission batches for this NDA filing. The audit involved an in-depth review and evaluation of all systems, procedures and processes related to the development, validation and manufacture of oral solids at the Bangalore site.

The state-of-the-art facility started cGMP production in 2008 and is designed to produce 5 billion tablets and capsules annually. The facility has been built-in with high flexibility to manage batch sizes from 10kg to 1000kg. Kemwell has been regularly shipping products to Europe and Australia from this facility, and will now soon start commercial supplies to Canada and USA.

About Kemwell Biopharma:

Kemwell Biopharma Pvt. Ltd., headquartered in Bangalore, India, is a pure-play global contract development and manufacturing company. The company manufactures pharmaceuticals for some of the world's top pharmaceutical companies, including GlaxoSmithKline, Bayer, Novartis and Pfizer. Kemwell is one of India's largest contract manufacturers of pharmaceuticals with over 30 years' experience. The company employs more than 1000 employees worldwide and has seven production facilities, five in India and two in Sweden. Kemwell is an approved pharmaceutical manufacturer in over 80 countries including the American, European, Japanese and Indian markets.

Read more about Kemwell on www.kemwellbiopharma.com.

Primary Media Contact: Karan Bagaria , karan.bagaria@kemwellpharma.com, 91-80-39286200

Secondary Media Contact: Bhaskar Vishwanathan , bhaskar.vishwanathan@kemwellpharma.com, 91-80-39286200


'/>"/>
SOURCE Kemwell Biopharma Pvt Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, ... Canada , today announced two new real-world data analyses ... 65 th Annual Pacific Coast Reproductive Society (PCRS) Meeting ... 24 th .   The results being presented are ... 2009 to December 2015 containing data from 15 fertility clinics ...
(Date:3/22/2017)... 22, 2017 NetworkNewsWire Editorial Coverage  ... Deciphering marijuana ... statements by White House officials. Federal laws are at odds ... medical and/or recreational use, and businesses like SinglePoint, Inc. (OTC: ... CRBP), Medical Marijuana, Inc. (OTC: MJNA), Cannabis Science, Inc. (OTC: ...
(Date:3/22/2017)... 2017 Biosensors International Group, Ltd. ("Biosensors" or the ... the enrollment of the first American patient in LEADERS FREE II, its ... will include sites in the United States , ... Italy , and the United Kingdom . ... The BioFreedom drug-coated stent (DCS) ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... 22, 2017 , ... In recognition of Colon Cancer Awareness ... on cancer patients, cancer centers and advocacy groups, and MJH Studios™, a leading ... “No Ifs, Ands, or Butts,” that focuses on Colorectal Cancer detection, prevention and ...
(Date:3/22/2017)... ... March 22, 2017 , ... Drs. Jennifer Houck, Lauren Smith, Heather Johnson and ... patients in need of skilled pediatric dentistry in Rock Hill, SC, without ... patients routine treatments, including cavities, sealants and fluoride applications, in a comfortable and fun ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... throughout north Jersey and the New York metropolitan region, is embarking on a ... for homeless families. , At present, more than two and a half million ...
(Date:3/22/2017)... ... March 22, 2017 , ... Schneider Insurance and Financial, a southern Montana ... the Yellowstone Valley region, is launching a charity event aimed at raising local support ... all of Montana State, and is home to a broad variety of animals from ...
(Date:3/22/2017)... ... ... The Senior Citizens League (TSCL) is calling on Congressional leadership to lift ... including the debt held by the Social Security Trust Fund. “Congressional inaction on ... House and Senate budget leaders. “In prior debates to lift the debt ceiling, ...
Breaking Medicine News(10 mins):